Loading...
Loading...
BSX| Name | Value |
|---|---|
| Revenues | 4,209.0M |
| Cost of Revenue | 1,312.0M |
| Gross Profit | 2,897.0M |
| Operating Expense | 2,164.0M |
| Operating I/L | 733.0M |
| Other Income/Expense | -64.0M |
| Interest Income | 0.0M |
| Pretax | 669.0M |
| Income Tax Expense | 200.0M |
| Net Income/Loss | 468.0M |
Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of medical devices for interventional medical specialties. The company's revenue is generated through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Its diverse product portfolio includes devices for diagnosing and treating gastrointestinal, pulmonary, urological, and pelvic conditions, as well as implantable cardiac devices, remote patient management systems, spinal cord stimulator systems, deep brain stimulation systems, interventional cardiology products, peripheral vascular treatments, and structural heart therapies.
